An overview of our work is provided through the selected publications below. For a complete list of publications, please see ORCID
Fahmi A, Schultz-Pernice I, and Alves MP. Ebola virus persistence and the hidden cost of immune privilege. Nat Microbiol, 2026. (Article)
Leoni S, Schultz-Pernice I, Krátka Z, Freiholz L, Fahmi A, David T, Golomingi A, Blank F, Beránková M, Dejmek M, Grandgirard D, Dijkman R, Růžek D, Eyer L, *Alves MP, and *Leib SL. Bemnifosbuvir and remdesivir inhibit tick-borne encephalitis virus infection in complementary in vitro and ex vivo disease models. Antiviral Res, 2026. (Article)
Pomar L, Dashraath P, Alves MP, and Baud D. West Nile Virus: A Neglected Risk for Maternal-Fetal Medicine in Europe? Lancet Infect Dis, 2025. (Article)
Schultz-Pernice I, Fahmi A, Brito F, Liniger M, Chiu YC, David T, Oliveira Esteves BI, Golomingi A, Zumkehr B, Gerber M, Jandrasits D, Züst R, Steiner S, Wotzkow C, Blank F, Engler OB, Summerfield A, Ruggli N, Baud D, and Alves MP. Monkeypox virus spreads from cell-to-cell and leads to neuronal death in human neural organoids. Nat Commun, 2025. (Article)
Schön J, Barut GT, Trüeb BS, Halwe NJ, Berenguer Veiga I, Kratzel A, Ulrich L, Kelly JN, Brügger M, Wylezich C, Taddeo A, Aguiar Moreira E, Túrós D, Grau-Roma L, Ahrens AK, Schlottau K, Britzke T, Breithaupt A, Corleis B, Kochmann J, Oliveira Esteves BI, Almeida L, Thomann L, Devisme C, Stalder H, Steiner S, Ochsenbein S, Schmied K, Labroussaa F, Jores J, V'kovski P, Cmiljanovic V, Alves MP, Benarafa C, Ebert N, Hoffmann D, Beer M, Thiel V. A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nat Microbiol, 2024. (Article)
Dashraath P, Alves MP, Schwartz DA, Nielsen-Saines K, and Baud D. Potential mechanisms of intrauterine transmission of monkeypox virus. Lancet Microbe, 2022. (Article)
Barut T, Halwe NJ, Taddeo A, Kelly JN, Schön J, Ebert N, Ulrich L, Devisme C, Steiner S, Trüeb BS, Hoffmann B, Berenguer Veiga I, Leborgne NGF, Moreira EA, Breithaupt A, Wylezich C, Höper D, Wernike K, Godel A, Thomann L, Flück V, Stalder H, Brügger M, Oliveira Esteves BI, Zumkehr B, Beilleau G, Kratzel A, Schmied K, Ochsenbein S, Lang RM, Wider M, Machahua C, Dorn P, Marti TM, Funke-Chambour M, Rauch A, Widera M, Ciesek S, Dijkman R, Hoffmann D, *Alves MP, *Benarafa C, *Beer M, and *Thiel V. The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype. Nat Commun, 2022. (Article)
Wang L, Aguiar Moreira EA, Kempf G, Miyake Y, Oliveira Esteves BI, Fahmi A, Schaefer JV, Dreier B, Yamauchi Y, Alves MP, Plückthun A, and Matthias P. Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways. Cell Rep, 2022. (Article)
Fahmi A, Brügger M, Démoulins T, Zumkehr B, Oliveira Esteves BI, Bracher L, Wotzkow C, Blank F, Thiel V, Baud D, and Alves MP. SARS-CoV-2 can infect and propagate in human placenta explants. Cell Rep Med, 2021. (Article)
Brügger M, Démoulins T, Barut GT, Zumkehr B, Oliveira Esteves BI, Mehinagic K, Haas Q, Schögler A, Rameix-Welti MA, Eléouët JF, Moehrlen U, Marti TM, Schmid RA, Summerfield A, Posthaus H, Ruggli N, Hall SRR, and Alves MP. Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection. PLOS Pathog, 2021. (Article)
Démoulins T, Brügger M, Zumkehr B, Oliveira Esteves BI, Mehinagic K, Fahmi A, Borcard L, Taddeo A, Jandrasits D, Posthaus H, Benarafa C, Ruggli N, and Alves MP. The specific features of the developing T cell compartment of the neonatal lung are a determinant of respiratory syncytial virus immunopathogenesis. PLOS Pathog, 2021. (Article)
